Cancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the University of Birmingham's Institute of Cancer and Genomic Sciences, as a Trustee and Member.
A study of more than 23,000 samples carried out by teams across the UK, including the University of Birmingham, shows Oxford Nanopore's COVID-19 test, LamPORE, is highly accurate for the detection of SARS-CoV-2.
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.
Results from the first national study of children with cancer who test positive from COVID-19 has found that these patients do not appear to be at any increased risk of severe COVID-19 infection.
New insights into the mechanisms behind how cancer-causing agents in the environment active genetic recombination in DNA could help to better predict which individuals are more susceptible to developing the disease.
Routine testing patients for COVID-19 before major surgery could reduce the risk of respiratory complications and save lives, a new study reveals.
A new study from the University of Birmingham has found that 50% of patients with a rare type of cancer that has spread into the lining of their abdomen may be suitable for immunotherapy treatment.
A new research centre which aims to overcome barriers for a common, but often overlooked cancer has opened at the University of Birmingham.
Professor Dion Gregory Morton, Barling Professor of Surgery, University of Birmingham, was awarded an OBE for services to Innovation in the NHS in the 2020 Queen's Birthday Honours.
The College of Medical and Dental Sciences has achieved the Athena SWAN Silver award from the Athena SWAN Foundation, recognising the College's commitment to gender equality.